Literature DB >> 27862321

PTENp1, a natural sponge of miR-21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinoma.

Ling Gao1,2, Wenhao Ren1,2, Linmei Zhang2, Shaoming Li1, Xinjuan Kong3, Hao Zhang2, Jianwei Dong2, Guangfeng Cai2, Changxiong Jin2, Danqing Zheng2, Keqian Zhi1,2.   

Abstract

PTENp1, non-coding RNA (ncRNA) pseudogene, is involved in oral squamous cell carcinoma (OSCC). The precise effects mediated by PTENp1 transcripts within intricate regulatory networks involving molecular interactions with ancestral gene PTEN and tumorigenicity in OSCC remain unclear. Here, we found that PTENp1 was aberrantly expressed in OSCC. There was a positive correlation between the expression levels of PTENp1 and PTEN. Further, we showed that PTENp1 acted as a competing endogenous RNA that protects PTEN transcripts from being inhibited by miR-21, and consequently inhibited proliferation and colony formation and triggered S-G2/M cell cycle arrest through the AKT pathway. Also, the homogeneous relationship between expression of PTENp1 and PTEN was confirmed in OSCC tumor xenografts. Finally, low expression of PTENp1 and PTEN was negatively associated with histological differentiation and OSCC prognosis. The present work provided the first evidence for the extraordinary crosstalk among PTENp1, PTEN, and miR-21, and rendered a new light on the treatment of OSCC.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  OSCC; PTEN; PTENp1; miR-21; proliferation

Mesh:

Substances:

Year:  2016        PMID: 27862321     DOI: 10.1002/mc.22594

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  32 in total

1.  PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer.

Authors:  R-K Li; J- Gao; L-H Guo; G-Q Huang; W-H Luo
Journal:  Cancer Gene Ther       Date:  2017-07-21       Impact factor: 5.987

2.  Pseudogenes: Four Decades of Discovery.

Authors:  Leonardo Salmena
Journal:  Methods Mol Biol       Date:  2021

Review 3.  World Workshop on Oral Medicine VII: Clinical evidence of differential expression of lncRNAs in oral squamous cell carcinoma: A scoping review.

Authors:  Monica Pentenero; Leah M Bowers; Ruwan Jayasinghe; Tami Yap; Sok Ching Cheong; Alexander Ross Kerr; Camile S Farah; Ilias Alevizos
Journal:  Oral Dis       Date:  2019-06       Impact factor: 3.511

Review 4.  The association of long non-coding RNA in the prognosis of oral squamous cell carcinoma.

Authors:  Agnik Haldar; Ajay Kumar Singh
Journal:  Genes Genomics       Date:  2022-01-13       Impact factor: 1.839

Review 5.  The Complex Landscape of PTEN mRNA Regulation.

Authors:  Erin Sellars; Martino Gabra; Leonardo Salmena
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

Review 6.  Prospects of Non-Coding Elements in Genomic DNA Based Gene Therapy.

Authors:  S P Simna; Zongchao Han
Journal:  Curr Gene Ther       Date:  2022       Impact factor: 4.676

7.  Polymorphisms in lncRNA PTENP1 and the Risk of Gastric Cancer in a Chinese Population.

Authors:  Yugang Ge; Yu He; Mingkun Jiang; Dakui Luo; Xiangkun Huan; Weizhi Wang; Diancai Zhang; Li Yang; Jundong Zhou
Journal:  Dis Markers       Date:  2017-08-28       Impact factor: 3.434

8.  Long non-coding RNA PTENP1 interacts with miR-193a-3p to suppress cell migration and invasion through the PTEN pathway in hepatocellular carcinoma.

Authors:  Yu-Yuan Qian; Kun Li; Quan-Yan Liu; Zhi-Su Liu
Journal:  Oncotarget       Date:  2017-11-06

Review 9.  Current research on head and neck cancer-associated long noncoding RNAs.

Authors:  Wei Song; Yimin Sun; Jie Lin; Xiaoqin Bi
Journal:  Oncotarget       Date:  2017-11-22

Review 10.  PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.

Authors:  Nahal Haddadi; Yiguang Lin; Glena Travis; Ann M Simpson; Najah T Nassif; Eileen M McGowan
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.